Merck sees $2.1 billion coronavirus hit to 2020 sales [Yahoo! Finance News]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance News
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New JerseyBy Manas MishraReuters) - Merck & Co Inc said on Tuesday it expects the coronavirus pandemic to reduce 2020 sales by more than $2 billion, and the U.S. drugmaker lowered its profit forecast as a big drop in doctors' office visits during the outbreak will take a hefty toll, sending its shares down more than 3%.Many of Merck's top-selling products, including blockbuster cancer drug Keytruda, are administered by physicians.Rival drugmakers Pfizer Inc on Tuesday stuck to its forecasts, and Eli Lilly and Co raised the top end of its 2020 profit outlook last week.But Merck is particularly vulnerable to stay-at-home efforts to curb the spread of the coronavirus and people avoiding doctors and hospitals over fear of becoming infected."Two-thirds of our products are physician administered, and that is probably somewhat unique and is causing the impact," Chief Financial Officer Robert Davis said on a conf
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Trials, Tempus AI Deal And Leadership Shifts Shape Valuation Story [Yahoo! Finance]Yahoo! Finance
- Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial [Yahoo! Finance]Yahoo! Finance
- Akeso Deepens Cadonilimab Story With Survival Data And Global GBM Trial [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Evaxion announces business update and full year 2025 financial results [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/24/26 - Form 10-K
- 2/17/26 - Form 13F-HR
- 2/13/26 - Form 144/A
- MRK's page on the SEC website